⚖️DEA Revocation Order Impacts Healthcare Business Compliance
The Drug Enforcement Administration (DEA) issued an Order to Show Cause proposing to revoke the registration of Mary Massullo, D.O. due to her lack of authority to handle controlled substances in Ohio, following the permanent revocation of her medical license. The decision emphasizes the importance of compliance with state regulations for medical practitioners and organizations involved in controlled substance handling.
Learn More⚡Combined Notice of Natural Gas Pipeline Rate Filings for 2025
The Department of Energy has issued a combined notice detailing various natural gas pipeline rate and refund report filings. The notice outlines specific applicants, descriptions of filings, and important dates for comments and interventions, ensuring stakeholders remain informed on regulatory changes affecting the natural gas industry.
Learn More📜Preliminary Results on Antidumping Duty for Glycine Imports
The U.S. Department of Commerce (Commerce) is issuing the preliminary results of the changed circumstances review (CCR) of the antidumping duty order on glycine from the People's Republic of China (China). Commerce preliminarily finds that Salvi Chemical Industries Limited (Salvi) is eligible to participate in an established certification process. We invite interested parties to comment on these preliminary results.
Learn More🔍HUD Announces New Matching Program to Combat Fraud in Housing Benefits
Pursuant to the Privacy Act of 1974, as amended by the Computer Matching and Privacy Act of 1988 and the Computer Matching and Privacy Protections Amendment of 1990 (Privacy Act), and following the Office of Management and Budget (OMB) guidance on the conduct of matching programs, notice is hereby given of the establishment of a matching program between the U.S. Department of Housing and Urban Development (HUD) and the Department of the Treasury, Bureau of the Fiscal Service, Do Not Pay (DNP) Treasury Working System. This program aims to enhance the detection and prevention of fraud, waste, abuse and improper and unsupported payments in Federal benefit programs administered by HUD.
Learn More✈️New Instrument Approach Procedures Regulations by FAA
This rule establishes, amends, suspends, or removes Standard Instrument Approach Procedures (SIAPS) and associated Takeoff Minimums and Obstacle Departure procedures (ODPs) for operations at certain airports. These regulatory actions are needed because of the adoption of new or revised criteria, or because of changes occurring in the National Airspace System, such as the commissioning of new navigational facilities, adding new obstacles, or changing air traffic requirements. These changes are designed to provide safe and efficient use of the navigable airspace and to promote safe flight operations under instrument flight rules at the affected airports.
Learn More⚖️DEA Denies Registration for Phong Tran, Implicating Business Compliance
The Drug Enforcement Administration (DEA) has denied the application of Dr. Phong H. Tran for a DEA Certificate of Registration due to his exclusion from federal healthcare programs and lack of state authority, highlighting significant regulatory compliance issues for healthcare practitioners and businesses affiliated with them.
Learn More🥛Enforcement Proceedings on Chocolate Milk Trademark Violations
Notice is hereby given that the U.S. International Trade Commission has determined to institute a formal enforcement proceeding relating to the general exclusion order ("GEO") issued on November 15, 2022 and cease and desist orders ("CDOs") issued on November 18, 2024, in the above-referenced investigation.
Learn More🚫Analysis of Baijes Bissonnet Pharmacy DEA Registration Denial
The Drug Enforcement Administration issued a denial notice to Baijes Bissonnet Pharmacy, highlighting significant compliance failures related to controlled substances. The notice outlines allegations of neglecting red flags indicating prescription abuse and diversion, leading to substantial legal risks and regulatory consequences for the pharmacy.
Learn More📡Notice on Distribution of Satellite Royalty Funds by Copyright Board
The Copyright Royalty Judges solicit comments on a motion of Allocation Phase claimants for partial distribution of 2022 satellite royalty funds.
Learn More🧪HHS Certified Laboratories for Federal Drug Testing Compliance
The Department of Health and Human Services (HHS) notifies Federal agencies of the laboratories and Instrumented Initial Testing Facilities (IITFs) currently certified to meet the standards of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines) using Urine and the laboratories currently certified to meet the standards of the Mandatory Guidelines using Oral Fluid.
Learn More